|
94 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2011-06-01 |
4817 |
|
93 |
(³ú°úÇבּ¸¼Ò ¼¼¹Ì³ª)The Role of cAMP-GEF II in neural function
|
°ü¸®ÀÚ |
2011-05-20 |
4873 |
|
92 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2011-04-25 |
4886 |
|
91 |
[Ŭ·¯½ºÅÍ »ç¾÷´Ü] ÃÊû¼¼¹Ì³ª °³ÃÖ-ƯÇã¹ýÀÎ ÀÌ·ë '¾È¹ÌÁ¤' º¯¸®»ç (2011.04.26)
|
°ü¸®ÀÚ |
2011-04-21 |
5611 |
|
90 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2011-04-15 |
5225 |
|
89 |
(³ú°úÇבּ¸¼Ò ¼¼¹Ì³ª)Genetic Engineering of Human Embryonic Stem Cells as Human Disease Model
|
°ü¸®ÀÚ |
2011-04-11 |
5254 |
|
88 |
(³ú°úÇבּ¸¼Ò ¼¼¹Ì³ª)Fibroblast Growth Factors: From Basic Research to Clinical Applications
|
°ü¸®ÀÚ |
2011-04-07 |
5153 |
|
87 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2010-11-22 |
4649 |
|
86 |
* WCU»ç¾÷´Ü ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2010-11-18 |
4721 |
|
85 |
³ú°úÇבּ¸¼Ò ½ÉÆ÷Áö¾ö Systems Neuroscience and Optogenetics
|
°ü¸®ÀÚ |
2010-11-17 |
5300 |
|
84 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò Ưº° °¿¬È¸
|
°ü¸®ÀÚ |
2010-11-17 |
5032 |
|
83 |
*Çѱ¹¿¬±¸Àç´Ü ±âÃÊ¿¬±¸º»ºÎ ÀǾàÇÐ´Ü ¿¬±¸Áö¿ø»ç¾÷ ¼³¸íȸ
|
°ü¸®ÀÚ |
2010-11-09 |
5188 |
|
82 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2010-10-25 |
5007 |
|
81 |
[ÃÊû¼¼¹Ì³ª °³ÃÖ]¿¬¼¼´ë °ø´ë ·ù¿øÇü ±³¼ö
|
°ü¸®ÀÚ |
2010-10-18 |
4827 |
|
80 |
*¼¼Æ÷±âÁú¿¬±¸¼Ò ÃÊû¼¼¹Ì³ª
|
°ü¸®ÀÚ |
2010-10-14 |
4645 |